One-Year Safety of Olodaterol Once Daily via Respimat (R) in Patients with GOLD 2-4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis

DSpace Repositorium (Manakin basiert)

One-Year Safety of Olodaterol Once Daily via Respimat (R) in Patients with GOLD 2-4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis

Autor(en): McGarvey, Lorcan; Niewoehner, Dennis; Magder, Sheldon; Sachs, Paul; Tetzlaff, Kay; Hamilton, Alan; Korducki, Lawrence; Bothner, Ulrich; Vogelmeier, Claus; Koch, Andrea; Ferguson, Gary T.
Tübinger Autor(en):
Tetzlaff, Kay
Erschienen in: Copd - Journal of Chronic Obstructive Pulmonary Disease (2015), Bd. 12, H. 5, S. 484-493
Verlagsangabe: Taylor & Francis Inc
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.3109/15412555.2014.991864
ISSN: 1541-2555
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: